Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mixed chimerism, and intrathymic clonal deletion in mice primed with allogeneic spleen cells

Transplantation

Volumn 63, Issue 11, 1997, Pages 1667-1673

  Zhang, Qi Wei ^a   Mayumi, Hisanori ^a,b   Umesue, Masayoshi ^a   Tomita, Yukihiro ^a   Nomoto, Kikuo ^a   Yasui, Hisataka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; DOSE RESPONSE; FIBROSARCOMA; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; CLONAL DELETION; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAFT SURVIVAL; LEUKOPENIA; MICE; MICE, INBRED AKR; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED CBA; SKIN TRANSPLANTATION; SPLEEN; THYMUS GLAND; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING;

EID: 0030948742     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199706150-00022     Document Type: Article

References (26)

1. Schwartz R, Dameshek W. Drug-induced immunological tolerance. Nature 1959; 183: 1682.
2. Meeker WR, Condie RM, Good RA, Varco RL. Alteration of homograft response by antimetabolites. Ann NY Acad Sci 1960; 87: 203.
3. Calne RY. The rejection of renal homograft inhibition in dogs by 6-mercaptopurine. Lancet 1960; 1: 417.
4. Uphoff DE. Drug-induced immunological "tolerancefor homotransplantation. Transplant Bull 1961; 28: 110.
5. McLaren A. Induction of tolerance to skin homografts in adult mice treated with 6-mercaptopurine. Transplant Bull 1961; 28: 479.
6. Berenbaum MC. Prolongation of homograft survival in mice with single doses of cyclophosphamide. Nature 1963; 200: 84.
7. Santos GW, Owens AH. A comparison of the effects of selected cytotoxic agents on allogeneic skin graft survival in rat. Bull Johns Hopkins Hosp 1965; 116: 327.
8. Floersheim GL. Curative potencies against amanitin poisoning by cytochrome C. Science 1972; 177: 808.
9. Aisenberg AC. Studies on cyclophosphamide-induced tolerance to sheep erythrocytes. J Exp Med 1967; 125: 833.
10. Nirmul G, Severin C, Taub RN. Cyclophosphamide-induced immunologic tolerance to skin homografts. Surg Forum 1971; 22: 287.
11. Marquet R, Heystek G. The induction and abolition of specific immunosuppression of heart allografts in rats by use of donor blood and cyclophosphamide. J Immunol 1975; 115: 405.
12. Kelly WD, McKneally MF, Oliveras F, Martinez C, Good RA. Cell-free antigenic material employed to produce tolerance to skin grafts: tissue sources, preservation, dose requirements and the effects of combined use with azathioprine and sublethal irradiation. Ann NY Acad Sci 1966; 129: 210.
13. Mayumi H, Umesue M, Nomoto K. Cyclophosphamide-induced immunological tolerance: an overview. Immunobiology 1996; 96: 129.
14. Tokuda N, Mayumi H, Himeno K, Gondo H, Fan JL, Nomoto K. Drug-induced in vitro tolerance to allogeneic antigens. II. Further analysis of in vitro-tolerized spleen cells in a fully allogeneic murine combination. Transplantation 1988; 45: 464.
15. Mayumi H, Himeno K, Tanaka K, Tokuda N, Fan JL, Nomoto K. Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients. Transplantation 1986; 42: 417.
16. Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Nomoto K. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion. J Immunol 1990; 145: 1303.
17. Mayumi H, Himeno K, Shin T, Nomoto K. Drug-induced tolerance to allografts in mice. IV. Mechanisms and kinetics of cyclophosphamide-induced tolerance. Transplantation 1985; 39: 209.
18. Mayumi H, Good RA. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. J Exp Med 1989; 169: 213.
19. Umesue M, Mayumi H, Nishimura Y, et al. Donor-specific prolongation of rat skin graft survival induced by rat-donor cells and cyclophosphamide under coadministration of monoclonal antibodies against T cell receptor αβ and natural killer cells in mice. Transplantation 1996; 61: 116.
20. Nishimura Y, Mayumi H, Tomita Y, Eto M, Maeda T, Nomoto K. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system. J Immunol 1991; 146: 2639.
21. Mayumi H, Nomoto K, Good RA. A surgical technique for experimental free skin grafting in mice. Jpn J Surg 1988; 18: 548.
22. Maeda T, Eto M, Nishimura Y, Nomoto KE, Kong YY, Nomoto KI. Direct evidence for clonal destruction of allo-reactive T cells in the mice treated with cyclophosphamide after allo-priming. Immunology 1993; 78: 113.
23. Maeda T, Eto M, Nishimura Y, Nomoto K, Kong YY, Nomoto K. Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice. J Immunol 1993; 150: 753.
24. + T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mis-disparate antigens. J Exp Med 1990; 171: 97.
25. Mayumi H, Good RA. Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction. Immunobiology 1989; 179: 86.
26. Kersh GJ, Allen PM. Essential flexibility in the T cell recognition of antigen. Nature 1996; 380: 495.